Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Assets (2016 - 2025)

Historic Return on Assets for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to 0.14%.

  • Fennec Pharmaceuticals' Return on Assets fell 1200.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.01% for FY2024, which is 5800.0% up from last year.
  • According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Return on Assets is 0.14%, which was down 1200.0% from 0.25% recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Return on Assets peaked at 0.07% during Q1 2024, and registered a low of 1.44% during Q2 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.64% (2021), whereas its average is 0.59%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -4700bps in 2023, then skyrocketed by 14800bps in 2024.
  • Quarter analysis of 5 years shows Fennec Pharmaceuticals' Return on Assets stood at 0.61% in 2021, then crashed by -55bps to 0.94% in 2022, then increased by 29bps to 0.67% in 2023, then soared by 101bps to 0.0% in 2024, then tumbled by -4028bps to 0.14% in 2025.
  • Its Return on Assets was 0.14% in Q3 2025, compared to 0.25% in Q2 2025 and 0.3% in Q1 2025.